Autophagy Enhancers Regulate Cholesterol-Induced Cytokine Secretion and Cytotoxicity in Macrophages
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective: Hypercholesterolaemia transforms macrophages into lipid-laden foam cells in circulation, which can activate the immune response. Compromised autophagy and inflammatory cytokines are involved in the pathogenesis and progression of metabolic diseases. The aim of this study was to identify the role of autophagy as a modulator of the inflammatory response and cytotoxicity in macrophages under hypercholesterolaemic conditions. Methods: High cholesterol-induced cytokine secretion and alteration of autophagy-associated molecules were confirmed by cytokine array and western blot analysis, respectively. To confirm whether autophagic regulation affects high cholesterol-induced cytokine release and cytotoxicity, protein levels of autophagic molecules, cell viability, and cytotoxicity were measured in cultured macrophages treated autophagy enhancers. Results: Cholesterol treatment increased cytokine secretion, cellular toxicity, and lactate dehydrogenase release in lipopolysaccharide (LPS)-primed macrophages. Concomitantly, altered levels of autophagy-related molecules were detected in LPS-primed macrophages under hypercholesterolaemic conditions. Treatment with autophagy enhancers reversed the secretion of cytokines, abnormally expressed autophagy-associated molecules, and cytotoxicity of LPS-primed macrophages. Conclusion: Autophagy enhancers inhibit inflammatory cytokine secretion and reduce cytotoxicity under metabolic disturbances, such as hypercholesterolaemia. Modulation of autophagy may be a novel approach to control the inflammatory response observed in metabolic diseases.
Abstract
Objective: Hypercholesterolaemia transforms macrophages into lipid-laden foam cells in circulation, which can activate the immune response. Compromised autophagy and inflammatory cytokines are involved in the pathogenesis and progression of metabolic diseases. The aim of this study was to identify the role of autophagy as a modulator of the inflammatory response and cytotoxicity in macrophages under hypercholesterolaemic conditions. Methods: High cholesterol-induced cytokine secretion and alteration of autophagy-associated molecules were confirmed by cytokine array and western blot analysis, respectively. To confirm whether autophagic regulation affects high cholesterol-induced cytokine release and cytotoxicity, protein levels of autophagic molecules, cell viability, and cytotoxicity were measured in cultured macrophages treated autophagy enhancers. Results: Cholesterol treatment increased cytokine secretion, cellular toxicity, and lactate dehydrogenase release in lipopolysaccharide (LPS)-primed macrophages. Concomitantly, altered levels of autophagy-related molecules were detected in LPS-primed macrophages under hypercholesterolaemic conditions. Treatment with autophagy enhancers reversed the secretion of cytokines, abnormally expressed autophagy-associated molecules, and cytotoxicity of LPS-primed macrophages. Conclusion: Autophagy enhancers inhibit inflammatory cytokine secretion and reduce cytotoxicity under metabolic disturbances, such as hypercholesterolaemia. Modulation of autophagy may be a novel approach to control the inflammatory response observed in metabolic diseases.
참고문헌 (27)
- Eckel RH, "The metabolic syndrome", Lancet, 365, pp.1415~1428 (2005)
- Alberti KG, "The metabolic syndrome--a new worldwide definition", Lancet, 366, pp.1059~1062 (2005)
- Westerterp M, "Deficiency of ATP-binding cassette transporters A1 and G1 in macrophages increases inflammation and accelerates atherosclerosis in mice", Circ Res, 112, pp.1456~1465 (2013)
- Tall AR, "Cholesterol, inflammation and innate immunity", Nat Rev Immunol, 15, pp.104~116 (2015)
- 박성호, "Regulation of Macrophage Activation and Differentiation in Atherosclerosis", 지질·동맥경화학회지, 10(3), pp.251~267 (2021), 한국지질동맥경화학회[DOI]
- Persson J, "Cytokine response to lipoprotein lipid loading in human monocyte-derived macrophages", Lipids Health Dis, 5, pp.17~ (2006)
- Groh L, "Monocyte and macrophage immunometabolism in atherosclerosis", Semin Immunopathol, 40, pp.203~214 (2018)
- Angelovich TA, "Inflammation-induced foam cell formation in chronic inflammatory disease", Immunol Cell Biol, 93, pp.683~693 (2015)
- Rubinsztein DC, "Autophagy modulation as a potential therapeutic target for diverse diseases", Nat Rev Drug Discov, 11, pp.709~730 (2012)
- Liu K, "Regulation of lipid stores and metabolism by lipophagy", Cell Death Differ, 20, pp.3~11 (2013)
- Levine B, "Autophagy in immunity and inflammation", Nature, 469, pp.323~335 (2011)
- Ko JH, "Rapamycin regulates macrophage activation by inhibiting NLRP3 inflammasome-p38 MAPK-NFκB pathways in autophagy-and p62-dependent manners", Oncotarget, 8, pp.40817~40831 (2017)
- Shappley RK, "Differential role of rapamycin and torin", KU63794 in inflammatory response of 264. 7 RAW macrophages stimulated by CA-MRSA, 2014, pp.2014, 560790~
- Myerowitz R, "Impaired autophagy : the collateral damage of lysosomal storage disorders", EBioMedicine, 63, pp.103166~ (2021)
- Yvan-Charvet Laurent, "Metabolic Reprogramming of Macrophages in Atherosclerosis: Is It All about Cholesterol?", 지질·동맥경화학회지, 9(2), pp.231~242 (2020), 한국지질동맥경화학회[DOI]
- O’Rourke SA, "Cholesterol crystals drive metabolic reprogramming and M1 macrophage polarisation in primary human macrophages", Atherosclerosis, 352, pp.35~45 (2022)
- Dong H, "Regulation of lipid droplets by autophagy", Trends Endocrinol Metab, 22, pp.234~240 (2011)
- Festa BP, "The pleiotropic roles of autophagy in Alzheimer’s disease : from pathophysiology to therapy", Curr Opin Pharmacol, 60, pp.149~157 (2021)
- 전소영, "Autophagy, Cellular Aging and Age-related Human Diseases", Experimental Neurobiology, 28(6), pp.643~657 (2019), 한국뇌신경과학회
- Jerome WG, "Lysosomes, cholesterol and atherosclerosis", Clin Lipidol, 5, pp.853~865 (2010)
- Mori M, "Foam cell formation containing lipid droplets enriched with free cholesterol by hyperlipidemic serum", J Lipid Res, 42, pp.1771~1781 (2001)
- Moreau K, "Cytoprotective roles for autophagy", Curr Opin Cell Biol, 22, pp.206~211 (2010)
- Lappalainen J, "Cholesterol loading suppresses the atheroinflammatory gene polarization of human macrophages induced by colony stimulating factors", Sci Rep, 11, pp.4923~ (2021)
- Ghanbari M, "Interleukin-1 in obesity-related low-grade inflammation : from molecular mechanisms to therapeutic strategies", Int Immunopharmacol, 96, pp.107765~ (2021)
- Jiang X, "Inflammasome-driven interleukin-1α and interleukin-1β production in atherosclerotic plaques relates to hyperlipidemia and plaque complexity", JACC Basic Transl Sci, 4, pp.304~317 (2019)
- Omoigui S, "The interleukin-6 inflammation pathway from cholesterol to aging--role of statins, bisphosphonates and plant polyphenols in aging and age-related diseases", Immun Ageing, 4, pp.1~ (2007)
- Jongstra-Bilen J, "Role of myeloid-derived chemokine CCL5", RANTES at an early stage of atherosclerosis, 2021, pp.156, 69~78